Invention Grant
- Patent Title: Oral octreotide administered in combination with other therapeutic agents
-
Application No.: US15972557Application Date: 2018-05-07
-
Publication No.: US10682387B2Publication Date: 2020-06-16
- Inventor: Asi Haviv
- Applicant: Chiasma, Inc.
- Applicant Address: US MA Needham
- Assignee: Chiasma, Inc.
- Current Assignee: Chiasma, Inc.
- Current Assignee Address: US MA Needham
- Agency: Goodwin Proctor LLP
- Main IPC: A61K38/12
- IPC: A61K38/12 ; A61K38/08 ; A61K45/06 ; C07K7/06 ; A61K38/31 ; A61K31/48 ; A61K31/135 ; A61K31/4745 ; A61K38/27
Abstract:
This invention relates to combination therapy of a subject suffering from acromegaly. The method of treatment comprises administration to the subject of a therapeutically effective amount of oral somatostatin receptor ligand (SRL) e.g. octreotide in combination with a therapeutically effective amount of a dopamine agonist and/or a growth hormone receptor antagonist and/or a selective estrogen receptor modulator (SERM) and/or a 2nd somatostatin receptor ligand (SRL).
Public/Granted literature
- US20190091285A1 ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS Public/Granted day:2019-03-28
Information query
IPC分类:
